LCI has proven to be a more effective and sensitive alternative than FEV1 to assess response to treatment with Ivacaftor in patients with CF who have the G551D-CFTR mutation and reduced lung function, but still normal spirometry [37]. This evidence concerns the gene CFTR and cystic fibrosis.